Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

Our findings indicate that the long-term use of danazol is associated with an increased risk for early atherosclerosis in patients with HAE. Consequently, monitoring of HDL and LDL levels at regular intervals is recommended during follow-up.